Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C42H82NO8P |
| Molecular Weight | 760.0761 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 2 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC
InChI
InChIKey=WTJKGGKOPKCXLL-VYOBOKEXSA-N
InChI=1S/C42H82NO8P/c1-6-8-10-12-14-16-18-20-21-23-25-27-29-31-33-35-42(45)51-40(39-50-52(46,47)49-37-36-43(3,4)5)38-48-41(44)34-32-30-28-26-24-22-19-17-15-13-11-9-7-2/h20-21,40H,6-19,22-39H2,1-5H3/b21-20-/t40-/m1/s1
| Molecular Formula | C42H82NO8P |
| Molecular Weight | 760.0761 |
| Charge | 0 |
| Count |
|
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 2 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/20392582Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/25817536
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20392582
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/25817536
POPC is a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine. It is an important phospholipid for biophysical experiments and has been used to study various subjects such as lipid rafts. POPC also used in systems mimicking the cell membrane. It was shown that endogenous lipid synthesis generates a discrete phosphatidylcholine species, 1-palmitoyl 2-oleyl phosphatidylcholine (16:0/18:1 PC), that serves as an endogenous ligand for PPARalpha. Myelin is a membrane characterized by high lipid content to facilitate impulse propagation. Changes in myelin fatty acid (FA) composition have been associated with peripheral neuropathy. It was also found that mice lacking sterol regulatory element-binding factor-1c (Srebf1c) have blunted peripheral nerve FA synthesis that results in development of peripheral neuropathy. Peripheral nerves lacking Srebf1c show decreased FA synthesis and glycolytic flux, but increased FA catabolism and mitochondrial function. These metabolic alterations are the result of local accumulation of two endogenous peroxisome proliferator-activated receptor-α (PARalpha) ligands, 1-palmitoyl-2-oleyl-sn-glycerol-3-phosphatidylcholine and 1-stearoyl-2-oleyl-sn-glycerol-3-phosphatidylcholine. Treatment with a PPARalpha antagonist rescues the neuropathy.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL239 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20392582 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:27:18 GMT 2025
by
admin
on
Mon Mar 31 18:27:18 GMT 2025
|
| Record UNII |
TE895536Y5
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5497103
Created by
admin on Mon Mar 31 18:27:18 GMT 2025 , Edited by admin on Mon Mar 31 18:27:18 GMT 2025
|
PRIMARY | |||
|
100000093374
Created by
admin on Mon Mar 31 18:27:18 GMT 2025 , Edited by admin on Mon Mar 31 18:27:18 GMT 2025
|
PRIMARY | |||
|
SUB30396
Created by
admin on Mon Mar 31 18:27:18 GMT 2025 , Edited by admin on Mon Mar 31 18:27:18 GMT 2025
|
PRIMARY | |||
|
TE895536Y5
Created by
admin on Mon Mar 31 18:27:18 GMT 2025 , Edited by admin on Mon Mar 31 18:27:18 GMT 2025
|
PRIMARY | |||
|
POPC
Created by
admin on Mon Mar 31 18:27:18 GMT 2025 , Edited by admin on Mon Mar 31 18:27:18 GMT 2025
|
PRIMARY | |||
|
DTXSID101029642
Created by
admin on Mon Mar 31 18:27:18 GMT 2025 , Edited by admin on Mon Mar 31 18:27:18 GMT 2025
|
PRIMARY | |||
|
248-056-7
Created by
admin on Mon Mar 31 18:27:18 GMT 2025 , Edited by admin on Mon Mar 31 18:27:18 GMT 2025
|
PRIMARY | |||
|
73001
Created by
admin on Mon Mar 31 18:27:18 GMT 2025 , Edited by admin on Mon Mar 31 18:27:18 GMT 2025
|
PRIMARY | |||
|
26853-31-6
Created by
admin on Mon Mar 31 18:27:18 GMT 2025 , Edited by admin on Mon Mar 31 18:27:18 GMT 2025
|
PRIMARY |